HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro.

Abstract
Monoclonal antibodies (Mabs) conjugated to toxins or their subunits (immunotoxins or ITs) are undergoing clinical testing in adults with a variety of malignancies. The potential impact of this form of therapy in pediatric precursor B-lineage acute lymphoblastic leukemia (pre-B ALL) has yet to be determined. Mabs directed against the cell surface antigens, CD19 and CD22 conjugated to deglycosylated ricin A chain (dgRTA) have been tested in patients with non-Hodgkin's lymphoma (NHL), but not in patients with pre-B ALL. Because of the encouraging performance of these ITs in phase I trials, we evaluated the specific cytotoxicity of anti-CD19 (HD37-dgRTA) and anti-CD22 (RFB4-dgRTA) ITs or their combination (Combotox) on patient-derived pre-B ALL cells maintained in vitro on a stromal feeder layer. After 48 h in culture, cytotoxicity to tumor cells was determined by flow cytometry using propidium iodide (PI) and fluorescein isothiocyanate (FITC)-conjugated anti-CD10, 19, and 22. Both RFB4-dgRTA and HD37-dgRTA induced a statistically significant reduction in the number of viable leukemic cells, and Combotox was even more effective. Our results demonstrate that these ITs are specifically cytotoxic to primary pre-B ALL cells and that they should be further evaluated for the therapy of B-lineage ALL.
AuthorsL Herrera, R A Farah, V A Pellegrini, D B Aquino, E S Sandler, G R Buchanan, E S Vitetta
JournalLeukemia (Leukemia) Vol. 14 Issue 5 Pg. 853-8 (May 2000) ISSN: 0887-6924 [Print] England
PMID10803517 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antigens, CD
  • Antigens, CD19
  • Antigens, Differentiation, B-Lymphocyte
  • CD22 protein, human
  • Cell Adhesion Molecules
  • Immunotoxins
  • Lectins
  • Sialic Acid Binding Ig-like Lectin 2
  • Ricin
Topics
  • Adult
  • Antibody Specificity
  • Antigens, CD (immunology)
  • Antigens, CD19 (immunology)
  • Antigens, Differentiation, B-Lymphocyte (immunology)
  • Apoptosis (drug effects)
  • Bone Marrow Cells (pathology)
  • Burkitt Lymphoma (immunology, pathology)
  • Cell Adhesion Molecules
  • Cell Survival (drug effects)
  • Child
  • Humans
  • Immunotoxins (toxicity)
  • Lectins
  • Lymphocytes (drug effects, immunology, pathology)
  • Preleukemia (immunology, pathology)
  • Ricin (toxicity)
  • Sialic Acid Binding Ig-like Lectin 2
  • Stromal Cells (drug effects, pathology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: